格隆汇12月11日丨中国同辐(01763.HK)公告，以下公告的中文原稿由中国同辐股份有限公司旗下一间于 全国中小企业股份转让系统上市的附属公司，原子高科股份有限公司(股份代号：430005)于中国境内发 布。 氟[F]贝他嗪是北京师范大学崔孟超教授团队与原子高科合作研发的成果，为具有完全自主知识产权的 一类新药，主要用于阿尔茨海默病的早期诊断。该药物在临床应用中表现出脑白质非特异性摄取显著降 低的特点，优于已获FDA批准的同类产品。 此次签约既是对双方前期合作成果的阶段性总结，更是高校与企业协同推动科研成果转化为国家战略生 产力的关键起点。当前核医学产业正迎来黄金发展期，原子高科凭借深厚行业积淀与鲜明产业特色，已 成为领域内核心力量。未来双方将以产学研协作为纽带，加速核心成果临床转化、搭建人才共育快车 道，参与全球核药新技术竞争，为我国核医学事业高质量发展筑牢根基。 2025年12月10日，原子高科股份有限公司(以下简称"原子高科")与北京师范大学(以下简称"北师大")在 北京举办科技成果转化签约暨产学研合作交流会，共同签署了氟[18F]贝他嗪项目《专利转让协议》与 《产学研合作协议》。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 CHINA ISOTOPE & RADIATION CORPORATION 中國同輻股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1763） 於其他海外監管市場發佈的公告 中國同輻附屬公司與北京師範大學簽署氟[18F]貝他嗪一類創新 核藥專利轉讓協議及產學研項目合作協議 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條的規定而發出。 於本公告日期，董事會成員包括執行董事肖亞飛先生、張軍旗先生、霍穎穎女士 及馬曉宇女士；非執行董事陳贊先生、丁建民先生及常晉峪女士；及獨立非執行 董事潘昭國先生、陳景善女士、盧闖先生及安銳先生。 公告编号：2025-059 证券代码：430005 证券简称：原子高科 主办券商：广发证券 以下公告的中文原稿由中國同輻股份有限公司旗下一間於全國中小企業股份轉讓 系統上市的附屬公司，原子高科股份有限公司（股份代號：430005）於中國境內發 佈 ...

Core Insights - The Chinese nuclear technology application industry is transitioning from a "follower" to a "leader" position, particularly in the nuclear medical field, with significant advancements in the supply of key isotopes and domestic market share of radiation therapy equipment [1][2][3] - The market for radioactive drugs is projected to grow from 9.3 billion yuan in 2025 to 26 billion yuan by 2030, indicating strong growth potential in the nuclear medical sector [3] - The "Nuclear Technology Application Industry High-Quality Development Three-Year Action Plan (2024-2026)" aims for the industry to achieve a direct economic output of 400 billion yuan by 2026, with a target of 600 billion yuan by the end of the 14th Five-Year Plan [3][5] Achievements - The successful production of Lu-177 isotope by Qinshan Nuclear Power, which is expected to meet domestic market needs for targeted cancer therapies, marks a significant milestone in self-sufficient isotope supply [1][4] - Over 90 radiation therapy devices have been approved for market use by the National Medical Products Administration, with more than 70% being domestic brands, reducing reliance on imports [2] - The development pipeline for new radioactive drugs has accelerated, with over 200 candidates entering clinical trials, enhancing treatment options for cancer [2] Challenges - The industry faces risks related to single-point dependency on key isotopes and insufficient elasticity in the supply chain, which could jeopardize stability in nuclear medicine and industrial applications [4] - There is a lack of understanding among small and medium enterprises regarding national support policies, leading to difficulties in seizing development opportunities [4] - Issues such as insufficient investment in basic research, weak pilot testing for technology transfer, and imbalanced regional development are hindering overall industry progress [4] Strategic Initiatives - The "Strong Chain Action Plan" was launched to address existing challenges and promote a systematic upgrade of the nuclear technology application industry, involving collaboration among state-owned enterprises, research institutions, and private companies [5][6] - The plan emphasizes a collaborative approach to enhance the entire industry chain, ensuring the stability of domestic isotope supply and fostering innovation through cross-sector integration [6] - The initiative aims to create industrial clusters in key regions to address developmental imbalances and stimulate growth across the industry [6]

AI赋能 核力倍增 核技术应用产业智能化提速 ● 本报记者 刘杨 当规模数千亿元、年均增速超15%的核技术应用产业，与正迈向价值创造阶段的人工智能技术相遇，一 场关乎效率革命、精度突破与场景拓展的产业变革已然发生。 "人工智能+核技术应用已显露出倍增效应，为这一重要引擎赋能增效，有望推动其在国民经济各领域 实现更深层次的融合与突破。"国家原子能机构原副主任、中国核能行业协会特邀专家王毅韧表示。中 国证券报记者通过多方调研发现，昔日高精尖的小众领域，如今正借助AI技术的东风，打破行业边 界、突破技术瓶颈，在安检、食品检测、新能源等多个领域实现创新突破。 智慧安检革新民生体验 AI赋能下的核技术，正以更贴近民生的姿态，渗透到公共安全领域的核心场景。记者调研了解到，过 去传统安检模式效率偏低，旅客需频繁取出电子设备、液体等物品，既耗时又不便，而"AI+核技术"的 融合应用，正彻底改变这一现状。 同方威视为香港国际机场打造的智能保安检查系统，便是这一融合的典型样本。"我们整合了手提行李 CT及智能回框系统、托运行李CT检查系统、毫米波人体安检仪等全套设备，而AI算法则实现了这些设 备的高效协同与智能升级。"同方威视副 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國同輻股份有限公司 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01763 | 說明 | H股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 79,968,800 | RMB | | 1 | RMB | | 79,968,800 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 79,968,800 | RMB | | 1 | RMB | | 79,968,800 | | 2. 股份分類 ...

Core Viewpoint - China Tongfu (01763) has signed a strategic cooperation agreement with China National Nuclear Corporation Capital Holdings Co., Ltd. to enhance the integration of the nuclear technology application industry chain and address key technological bottlenecks [1] Group 1: Strategic Cooperation - The agreement focuses on resource sharing and complementary advantages to promote the integration of the nuclear technology application industry chain [1] - Both parties aim to collaborate deeply in areas such as mergers and acquisitions, new company establishment, equity investment, and securities business [1] - The cooperation seeks to create a new pattern of coordinated development between technology and finance, as well as industry and finance [1] Group 2: Goals and Objectives - The core objectives include breaking through critical technological bottlenecks and cultivating new productive forces [1] - The partnership is designed to empower China Tongfu to achieve high-quality development through financial capital [1]

Core Insights - China Tongfu (01763.HK) signed a strategic cooperation agreement with China National Nuclear Corporation Capital Holdings Co., Ltd. at the second Nuclear Technology Application Industry Chain Co-Chain Action Conference on November 27 [1] Group 1: Strategic Cooperation - The agreement focuses on promoting the integration of the nuclear technology application industry chain and overcoming key technological bottlenecks [1] - The collaboration aims to cultivate new productive forces through resource sharing and complementary advantages [1] Group 2: Areas of Collaboration - The partnership will involve deep cooperation in areas such as mergers and acquisitions, establishment of new companies, equity investments, and securities business [1] - The goal is to create a new pattern of coordinated development between technology and finance, as well as industry and finance [1] Group 3: Development Goals - The strategic cooperation is designed to empower China Tongfu with financial capital to achieve high-quality development [1]

中國同輻股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1763） 自願性公告 CHINA ISOTOPE & RADIATION CORPORATION 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 中國同輻與中核資本簽署《戰略合作協議》 以金融資本賦能高質量發展 本公告乃中國同輻股份有限公司（「中國同輻」或「本公司」）自願發出以使股東及潛 在投資者知悉本公司之最新業務進展。 本公司董事會（「董事會」）欣然宣佈，11月27日，在中國核工業集團有限公司、中 國同位素與輻射行業協會主辦的第二屆核技術應用產業鏈共鏈行動大會上，中國 同輻與中國核工業集團資本控股有限公司（「中核資本」）簽署《戰略合作協議》。 根據《戰略合作協議》，雙方將聚焦推動核技術應用產業鏈整合、突破關鍵技術 「卡脖子」瓶頸、培育新質生產力的核心目標，通過資源共享、優勢互補，在併購 擴張、新設公司、股權投資、證券業務等方面開展深度協作，構建科技與金融、 產業與金融 ...

Core Points - China Tongfu (01763) signed a contract for an agricultural gamma irradiation project in Lima, Peru on November 17, 2025 [1] - The project aims to enhance sterilization levels and extend shelf life for Peruvian agricultural products, improving export quality and market competitiveness [1] - This project aligns with the "Atoms for Food" initiative by the International Atomic Energy Agency (IAEA), promoting food security and sustainable agricultural development [1] - The project represents a deepening of practical cooperation between China and Peru in the field of nuclear technology application [1] - It also expands new opportunities for China's nuclear technology to "go global" [1]

Core Viewpoint - China Tongru's signing of the gamma irradiation station project in Peru aims to enhance the quality and competitiveness of Peruvian agricultural products in the export market [1] Group 1 - On November 17, 2025, China Tongru officially signed a contract for the agricultural gamma irradiation station project with local owners in Lima, Peru [1] - The agreement includes the provision of professional gamma irradiation equipment and a comprehensive solution for supplying irradiation cobalt sources [1] - The project will primarily focus on the irradiation treatment of agricultural products, aiming to improve sterilization levels and extend product shelf life [1]